查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1618200

血流动力学监测设备市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Hemodynamic Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球血流动力学监测设备市场价值14 亿美元，预计2024 年至2032 年复合年增长率为6.7%。血流和压力。它们提供关键生理参数的即时资料，例如心输出量、血压、氧合水平和血管阻力，使医疗保健提供者能够有效评估心臟功能和体液平衡。包括心臟病和高血压在内的心血管疾病的盛行率不断上升，是市场成长的重要动力。血流动力学监测设备对于管理慢性和急性心血管疾病、指导治疗和改善患者预后是不可或缺的。

从产品来看，血流动力学监测设备市场分为一次性用品和监视器。 2023 年一次性用品部分的价值为 4.379 亿美元。在重症监护环境中，患者的免疫系统通常受到损害，导管、压力感测器和电极等无菌一次性物品对于防止病原体传播至关重要。根据系统类型，血流动力学监测设备市场分为非侵入性、侵入性和微创细分市场。

非侵入性细分市场在 2023 年占据主导地位，营收为 7.192 亿美元，预计在预测期内复合年增长率为 6.8%。医疗保健提供者和患者越来越倾向于微创或非侵入性医疗保健选择。与传统的侵入性监测系统相比，非侵入性血流动力学监测设备越来越受欢迎，因为它们能够降低併发症风险、最大限度地减少患者不适并缩短恢復时间。此外，感测器技术、无线通讯和资料处理的技术进步提高了非侵入性血流动力学监测设备的准确性和可靠性。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 14亿美元
预测值 25亿美元
复合年增长率 6.7%

预计到2032 年，北美血流动力学监测设备市场将达到8.881 亿美元。美元，凸显了对先进监控系统的迫切需求。鑑于这些疾病的高发生率，准确可靠的血流动力学监测对于有效管理这些疾病至关重要。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球慢性病发生率上升
      • 血流动力学监测设备的技术进步
      • 越来越多地采用远端血流动力学监测设备
      • 人们越来越喜欢远距医疗服务
    • 产业陷阱与挑战
      • 病患监护设备成本高
      • 严格的监管框架
  • 成长潜力分析
  • 监管环境
    • 我们
    • 欧洲
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 免洗用品
  • 显示器

第 6 章：市场估计与预测：按系统类型，2021 - 2032 年

  • 主要趋势
  • 非侵入性
  • 侵入性
  • 微创

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 家庭护理设置
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章：公司简介

  • Abbott Laboratories
  • Baxter International
  • Canon Medical Systems Corporation
  • Deltex Medical Group
  • Edwards Lifesciences Corporation
  • GE HealthCare Technologies
  • Getinge
  • ICU Medical
  • Koninklijke Philips NV
  • Masimo Corporation
  • Nihon Kohden Corporation
  • OSYPKA MEDICAL
  • Siemens Healthineers
简介目录
Product Code: 7995

The Global Hemodynamic Monitoring Devices Market was worth USD 1.4 billion in 2023, with an estimated CAGR of 6.7% from 2024 to 2032. These devices are crucial for assessing and tracking cardiovascular performance, specifically monitoring blood flow and pressure within the circulatory system. They provide real-time data on critical physiological parameters, such as cardiac output, blood pressure, oxygenation levels, and vascular resistance, enabling healthcare providers to evaluate heart function and fluid balance effectively. The increasing prevalence of cardiovascular conditions, including heart disease and hypertension, is a significant driver of market growth. Hemodynamic monitoring devices are indispensable for managing chronic and acute cardiovascular conditions, guiding treatment, and improving patient outcomes.

In terms of products, the hemodynamic monitoring device market is divided into disposables and monitors. The disposables segment was valued at USD 437.9 million in 2023. Single-use disposables are essential for minimizing the risk of cross-contamination and hospital-acquired infections (HAIs). In critical care settings, where patients often have compromised immune systems, sterile single-use items like catheters, pressure transducers, and electrodes are vital for preventing pathogen transmission. Based on system type, the hemodynamic monitoring devices market is divided into non-invasive, invasive, and minimally invasive segments.

The non-invasive segment dominated in 2023 with a revenue of USD 719.2 million, and it is expected to grow at a CAGR of 6.8% over the forecast period. There is a growing preference for minimally invasive or non-invasive healthcare options among healthcare providers and patients. Non-invasive hemodynamic monitoring devices are increasingly popular because of their ability to reduce complication risks, minimize patient discomfort, and shorten recovery times compared with traditional invasive monitoring systems. Additionally, technological advancements in sensor technology, wireless communication, and data processing have enhanced the accuracy and reliability of non-invasive hemodynamic monitoring devices.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.4 Billion
Forecast Value$2.5 Billion
CAGR6.7%

North America hemodynamic monitoring devices market is forecast to reach USD 888.1 million by 2032. U.S. market held a revenue of USD 470.5 million in 2023, driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders across the region, highlighting the critical need for advanced monitoring systems. Accurate and reliable hemodynamic monitoring is essential for effectively managing these conditions, given the high incidence rates.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Technological advancements in hemodynamic monitoring devices
      • 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
      • 3.2.1.4 Growing preference for telehealth services
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of patient monitoring devices
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Disposables
  • 5.3 Monitors

Chapter 6 Market Estimates and Forecast, By System Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Non-invasive
  • 6.3 Invasive
  • 6.4 Minimally invasive

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Homecare settings
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Baxter International
  • 9.3 Canon Medical Systems Corporation
  • 9.4 Deltex Medical Group
  • 9.5 Edwards Lifesciences Corporation
  • 9.6 GE HealthCare Technologies
  • 9.7 Getinge
  • 9.8 ICU Medical
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Masimo Corporation
  • 9.11 Nihon Kohden Corporation
  • 9.12 OSYPKA MEDICAL
  • 9.13 Siemens Healthineers